Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine

201124 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Cancer Immunology Immunotherapy

Volume 60, Issue 7, pp. 1039-1045

Field-Weighted Citation Impact: 1.23